Transdermal Diagnostics Ltd

medical devices

About

Transdermal Diagnostics Ltd is a UK-based MedTech startup founded in August 2021. The company focuses on developing non-invasive wearable technology for chronic disease diagnosis and management, particularly diabetes. Headquartered in Bristol, it operates as a private limited entity and is a spin-out from the University of Bath. The company's flagship product is the world's first 100% needle-free continuous glucose monitor. This innovative wearable platform features a disposable adhesive skin patch that extracts biological substances through hair follicles, eliminating the need for needles or blood samples. It includes a rechargeable transmitter that communicates wirelessly with a smartphone app. This technology aims to provide an affordable and pain-free solution for continuous glucose monitoring, targeting individuals with Type 1 and Type 2 diabetes, as well as those with prediabetes. Transdermal Diagnostics is committed to making remote health monitoring accessible and empowering users to manage their health proactively.

Technologies

Gmail Google Apps GoDaddy Hosting Android Render Docker Remote Circle Reviews AI

Keywords

medical devices transdermal biosensor continuous glucose monitoring monitoring platform health tracker medtech chronic diseases medical equipment manufacturing biotechnology biomarker sensing personalized health tracking real-time blood glucose skin barrier preservation d2c preventive health technology clinical validation medical equipment and supplies manufacturing digital health patient adherence biomarker multiplexing healthcare technology digital health monitoring medical device development biomedical sensors scalable medtech solutions non-invasive glucose sensing digital therapeutics medical wearables hair follicle sensing

Location

Claverton Down, England, United Kingdom, BA2 7AY

Related Companies

Companies in the same industry